LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Atropine Sulfate Injection, USP in an 8 mg per 20 mL presentation. Fresenius Kabi ...
Atropine is a muscarinic antagonist and is indicated for temporary blockage of severe or life threatening muscarinic effects. Atropine Sulfate Injection is now available in an 8mg per 20mL ...
MicroDose Therapeutx Announces Successful Completion of Phase 1 Pilot Study with Inhaled Atropine as Antidote to Combat Effects of Nerve Agent Poisoning MONMOUTH JUNCTION, N.J.--(BUSINESS ...
Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results